| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |